Understanding how sugar modifications on tau protein affect Alzheimer's disease
Dissecting the role of tau glycosylation in Alzheimer's disease
This study is looking at how sugar changes to a protein called tau, which is connected to Alzheimer's disease, affect its behavior in the brain, and it's for anyone interested in understanding more about how these changes might help us find new ways to treat the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-10662150 on NIH RePORTER |
What this research studies
This research investigates the role of glycosylation, a type of sugar modification, on the tau protein, which is linked to Alzheimer's disease. The study aims to explore how these modifications influence tau's behavior in the brain, particularly its structure and how it interacts with cells. Researchers will examine the effects of glycosylation alongside other modifications and assess how these changes impact the protein's stability and toxicity in neurons derived from human stem cells. By addressing these questions, the research seeks to fill critical gaps in our understanding of tau's role in Alzheimer's and pave the way for new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to tau protein modifications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapeutic and diagnostic approaches for Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding protein modifications in neurodegenerative diseases, suggesting potential for success in this area.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Walczak, Maciej — University of Colorado
- Study coordinator: Walczak, Maciej
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.